Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "established-brands"

12 News Found

Lupin to acquire supplements portfolio of Anglo-French Drugs & Industries for Rs 325 crore
News | January 18, 2022

Lupin to acquire supplements portfolio of Anglo-French Drugs & Industries for Rs 325 crore

The acquisition would enable addition of established brands with high recall amongst healthcare professionals, especially in the vitamins, minerals and supplements category

GlaxoSmithKline posts Q2FY22 consolidated PAT at Rs. 204.24 Cr
News | November 01, 2021

GlaxoSmithKline posts Q2FY22 consolidated PAT at Rs. 204.24 Cr

GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021

Latest Stories

Apollo launches its 76th hospital, boosts tech-led healthcare in India

Lilly buys Ajax Therapeutics for up to $2.3 billion to target rare blood cancers

Concept Medical unveils promising 3-year data for sirolimus balloon therapy

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
The next big opportunity lies in immune and rare disease white spaces: Venkat Nelabhotla, President & CEO, Vyome Holdings
The next big opportunity lies in immune and rare disease white spaces: Venkat Nelabhotla, President & CEO, Vyome Holdings
Venkat Nelabhotla Co-Founder, President & CEO, Vyome Holdings, Inc.
Local manufacturing, deeper CDMO ties, region-specific solutions remain our top priorities in next 3–5 years: Ganesh Bade, Director Bioprocessing–IMEA, Avantor
Local manufacturing, deeper CDMO ties, region-specific solutions remain our top priorities in next 3–5 years: Ganesh Bade, Director Bioprocessing–IMEA, Avantor
Ganesh Bade Director Bioprocessing–IMEA, Avantor
We believe in trust-driven clinical conversations to cut through medical misinformation: Saurav Kasera, Founder, CLIRNET
We believe in trust-driven clinical conversations to cut through medical misinformation: Saurav Kasera, Founder, CLIRNET
Saurav Kasera Founder, CLIRNET

Packaging